))
A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?”
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 02, 2024 04:09 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 309008730 series 3025226
محتوای ارائه شده توسط A Second Opinion Archives - WebTalkRadio.net. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط A Second Opinion Archives - WebTalkRadio.net یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Host TS Wiley interviews mainstream oncologist Julie Taguchi from Sansum Clinic in Santa Barbara, California on the memory loss attendant with estrogen deprivation and chemotherapy. In the interview they also cover the validity of big pharma testing on oncology drugs versus no treatment at all. This is a candid and frank interview with someone on the inside of the standard of care in breast cancer treatment. This isn’t a show you want to miss!
The post A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?” appeared first on WebTalkRadio.net.
20 قسمت
اشتراک گذاری
